Care for patients with multiple endocrine neoplasia type 1: the current evidence base (Q37808142)

23 August 2017

Care for patients with multiple endocrine neoplasia type 1: the current evidence base (English)

1 reference

multiple endocrine neoplasia

23 August 2017

1 reference

multiple endocrine neoplasia type 1

inferred from title

1 reference

2

M R Vriens

1 reference

23 August 2017

C R C Pieterman

1

1 reference

23 August 2017

K M A Dreijerink

series ordinal

3

1 reference

23 August 2017

R B van der Luijt

series ordinal

4

1 reference

23 August 2017

G D Valk

series ordinal

5

1 reference

23 August 2017

1 March 2011

1 reference

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

1

1 reference

23 August 2017

157-171

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-010-9398-6

23 August 2017

0 references

cites work

Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved.

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Genetic aspects of adenomatosis of endocrine glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Positional cloning of the gene for multiple endocrine neoplasia-type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Characterization of mutations in patients with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

An Intronic mutation is associated with prolactinoma in a young boy, decreased penetrance in his large family, and variable effects on MEN1 mRNA and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Are patients with multiple endocrine neoplasia type I prone to premature death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple endocrine neoplasia type 1: a chromatin writer's block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Pituitary adenoma predisposition caused by germline mutations in the AIP gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: Choice of surgical procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Duodenal glucagonoma: A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

EUS Detection of Pancreatic Endocrine Tumors in Asymptomatic Patients with Type 1 Multiple Endocrine Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Surgery to cure the Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Long-term follow-up of patients with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Well-differentiated gastric tumors/carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Adrenal lesion in multiple endocrine neoplasia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Clinical practice. The incidentally discovered adrenal mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Somatostatinoma: clinico-pathological features of three cases and literature reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Treatment of type II gastric carcinoid tumors with somatostatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Endocrine pancreatic tumors: factors correlated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Gonadotroph Tumor Associated with Multiple Endocrine Neoplasia Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

Clinical Testing for Mutations in theMEN1Gene in Sweden: A Report on 200 Unrelated Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-010-9398-6

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors

21 January 2018

1 reference

12 December 2020

Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

1 reference

12 December 2020

Thymic carcinoids in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?

1 reference

12 December 2020

Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Cause of death in multiple endocrine neoplasia type 1

1 reference

12 December 2020

The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?

1 reference

12 December 2020

Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I

1 reference

12 December 2020

Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias

1 reference

12 December 2020

Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study

1 reference

12 December 2020

Genotype-phenotype analysis in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Discriminating capacity of indole markers in the diagnosis of carcinoid tumors

1 reference

12 December 2020

Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I.

1 reference

12 December 2020

Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Zollinger-Ellison syndrome. Clinical presentation in 261 patients

1 reference

12 December 2020

Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms.

1 reference

12 December 2020

Lethality of multiple endocrine neoplasia type I

1 reference

12 December 2020

Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal o

1 reference

12 December 2020

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

1 reference

12 December 2020

Adrenal involvement in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series

1 reference

12 December 2020

Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form

1 reference

12 December 2020

Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach.

1 reference

12 December 2020

The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism

1 reference

12 December 2020

CASE RECORDS of the Massachusetts General Hospital Weekly Clinicopathological Exercises: Case 39501

1 reference

12 December 2020

Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers

1 reference

12 December 2020

Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN 1 syndrome

1 reference

12 December 2020

Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?

1 reference

12 December 2020

Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.

1 reference

12 December 2020

Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up

1 reference

12 December 2020

Surgical management of insulinoma associated with multiple endocrine neoplasia type I

1 reference

12 December 2020

Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors

1 reference

12 December 2020

[Insulinomas in multiple endocrine neoplasia type 1. Report of a series of 44 cases by the multiple endocrine neoplasia study group]

1 reference

12 December 2020

Insulinoma--experience from 1950 to 1995.

1 reference

12 December 2020

Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)

1 reference

12 December 2020

Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE

1 reference

12 December 2020

Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.

1 reference

12 December 2020

The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1

1 reference

12 December 2020

Multiple endocrine neoplasia type 1 and adrenal lesions

1 reference

12 December 2020

The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease

1 reference

12 December 2020

Somatostatin receptor scintigraphy in liver metastasis detection from gastroenteropancreatic neuroendocrine tumors.

1 reference

12 December 2020

Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry

1 reference

12 December 2020

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis

1 reference

12 December 2020

Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases

1 reference

12 December 2020

Malignant endocrine tumors in patients with MEN 1 disease

1 reference

12 December 2020

Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1

1 reference

12 December 2020

High success rate of parathyroid reoperation may be achieved with improved localization diagnosis.

1 reference

12 December 2020

Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both

1 reference

12 December 2020

Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands

1 reference

12 December 2020

Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome

1 reference

12 December 2020

Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients

1 reference

12 December 2020

Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1

1 reference

12 December 2020

Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1

1 reference

12 December 2020

Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation

1 reference

12 December 2020

Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones

1 reference

12 December 2020

Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing

1 reference

12 December 2020

A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.

1 reference

12 December 2020

An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors

1 reference

12 December 2020

Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.

1 reference

12 December 2020

Clinical studies of multiple endocrine neoplasia type 1 (MEN1)

1 reference

12 December 2020

The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1

1 reference

12 December 2020

Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas

1 reference

12 December 2020

The influence of surgery in MEN-1 syndrome: observations over 150 years

1 reference

12 December 2020

Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity

1 reference

12 December 2020

FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX

1 reference

12 December 2020

Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1

1 reference

12 December 2020

Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome

1 reference

12 December 2020

Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern

1 reference

12 December 2020

Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Metastatic prolactinoma presenting as a cervical spinal cord tumour in multiple endocrine neoplasia type one (MEN-1)

1 reference

12 December 2020

Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.

1 reference

12 December 2020

Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia

1 reference

12 December 2020

Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Carcinoids associated with multiple endocrine neoplasia syndromes

1 reference

12 December 2020

Surgical management of hyperinsulinism in the multiple endocrine neoplasia, type 1 syndrome

1 reference

12 December 2020

Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group

1 reference

12 December 2020

Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates

1 reference

12 December 2020

Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1

1 reference

12 December 2020

Hyperparathyroidism in multiple endocrine neoplasia syndrome

1 reference

12 December 2020

10.1007/S10689-010-9398-6

Identifiers

DOI

1 reference

23 August 2017

1 reference